{"id":556685,"date":"2026-05-30T12:30:00","date_gmt":"2026-05-30T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=556685"},"modified":"2026-05-30T13:48:59","modified_gmt":"2026-05-30T11:48:59","slug":"opcoes-de-terapia-imune-e-direcionada-situacao-da-evidencia-2025-2026","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/opcoes-de-terapia-imune-e-direcionada-situacao-da-evidencia-2025-2026\/","title":{"rendered":"Op\u00e7\u00f5es de terapia imune e direcionada: Situa\u00e7\u00e3o da evid\u00eancia 2025\/2026"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>O tratamento do carcinoma urotelial desenvolveu-se significativamente nos \u00faltimos anos. As imunoterapias modernas, os conjugados anticorpo-f\u00e1rmaco (ADC) e as subst\u00e2ncias-alvo complementam as quimioterapias convencionais e permitem cada vez mais estrat\u00e9gias de tratamento individualizadas. Novos dados de 2025 e 2026 mostram que as terapias combinadas, os conceitos de manuten\u00e7\u00e3o e as abordagens baseadas em biomarcadores, em particular, est\u00e3o a ganhar import\u00e2ncia. O planeamento moderno da terapia tamb\u00e9m beneficia de diagn\u00f3sticos mais precisos.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fopcoes-de-terapia-imune-e-direcionada-situacao-da-evidencia-2025-2026%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>O tratamento do carcinoma urotelial desenvolveu-se significativamente nos \u00faltimos anos. As imunoterapias modernas, os conjugados anticorpo-f\u00e1rmaco (ADC) e as subst\u00e2ncias-alvo complementam as quimioterapias convencionais e permitem cada vez mais estrat\u00e9gias&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fopcoes-de-terapia-imune-e-direcionada-situacao-da-evidencia-2025-2026%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":556689,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Carcinoma urotelial ","footnotes":""},"category":[11551,11521,11524,11379,11507],"tags":[92663,92698,49901,92662,92656,92671,18834,92708,17515,92675,92695,92678,78106,92661,92688,92691,92669,92706,92701,92697,67229,92693,92654,92686,92684,92703,92682,15814,92680,90056,92676,92655,92659,92660,92658,11773,92657,92672,92665,92667],"powerkit_post_featured":[],"class_list":["post-556685","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-estudos","category-formacao-continua","category-oncologia-pt-pt","category-urologia-pt-pt","tag-analise-de-propensao","tag-anticorpos-substancia-ativa-conjugados","tag-biologia-tumoral","tag-bl-b01d1","tag-capacidades-pet-ct-suica","tag-capelao-meier-pfs-os","tag-carcinoma-da-bexiga","tag-carcinoma-do-trato-urinario","tag-carcinoma-urotelial","tag-carcinoma-urotelial-com-metastases","tag-combinacao-de-carboplatina","tag-combinacao-de-durvalumab","tag-comissoes-interdisciplinares-de-tumores","tag-disitamab-vedotina","tag-enfortumab-vedotina","tag-evp","tag-evidencia-do-mundo-real-evp","tag-expressao-da-nectina-4","tag-expressao-de-her2","tag-gemcitabina-cisplatina","tag-imagem-funcional","tag-imunoterapia-urotelial","tag-inibidores-do-ponto-de-controlo-imunitario-2","tag-javelin-bexiga100","tag-manutencao-do-avelumab","tag-mutacao-fgfr3","tag-nectina-4-pet","tag-pembrolizumab-pt-pt","tag-prognostico-da-pet-ct","tag-quimioterapia-a-base-de-platina","tag-quimioterapia-neoadjuvante","tag-sistema-de-saude-suico-oncologia","tag-terapia-baseada-em-biomarcadores","tag-terapia-dirigida-ao-fgfr","tag-terapia-dirigida-ao-her2","tag-terapia-orientada","tag-terapia-sequencial-urotelial","tag-terapia-urotelial-de-primeira-linha","tag-terapia-urotelial-de-segunda-linha","tag-toripalimab","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-15 05:48:30","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":556678,"slug":"opciones-de-terapia-inmunologica-y-dirigida-situacion-de-las-pruebas-2025-2026","post_title":"Opciones de terapia inmunol\u00f3gica y dirigida: Situaci\u00f3n de las pruebas 2025\/2026","href":"https:\/\/medizinonline.com\/es\/opciones-de-terapia-inmunologica-y-dirigida-situacion-de-las-pruebas-2025-2026\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=556685"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556685\/revisions"}],"predecessor-version":[{"id":556690,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556685\/revisions\/556690"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/556689"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=556685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=556685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=556685"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=556685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}